Artificial Intelligence in Pharmaceutical Sciences
Mingkun Lu,Jiayi Yin,Qi Zhu,Gaole Lin,Minjie Mou,Fuyao Liu,Ziqi Pan,Nanxin You,Xichen Lian,Fengcheng Li,Hongning Zhang,Lingyan Zheng,Wei Zhang,Hanyu Zhang,Zihao Shen,Zhen Gu,Honglin Li,Feng Zhu
DOI: https://doi.org/10.1016/j.eng.2023.01.014
IF: 12.834
2023-04-01
Engineering
Abstract:Drug discovery and development affects various aspects of human health and dramatically impacts the pharmaceutical market. However, investments in a new drug often go unrewarded due to the long and complex process of drug research and development (R&D). With the advancement of experimental technology and computer hardware, artificial intelligence (AI) has recently emerged as a leading tool in analyzing abundant and high-dimensional data. Explosive growth in the size of biomedical data provides advantages in applying AI in all stages of drug R&D. Driven by big data in biomedicine, AI has led to a revolution in drug R&D, due to its ability to discover new drugs more efficiently and at lower cost. This review begins with a brief overview of common AI models in the field of drug discovery; then, it summarizes and discusses in depth their specific applications in various stages of drug R&D, such as target discovery, drug discovery and design, preclinical research, automated drug synthesis, and influences in the pharmaceutical market. Finally, the major limitations of AI in drug R&D are fully discussed and possible solutions are proposed.
engineering, multidisciplinary